Table 4:

MR imaging signs of CSH in 19 patients^a

Patient No.	Increased Pituitary Height^b		Engorged Venous Sinuses	Narrow Ventricles	Dural Enhancement	Subdural Effusion	Brain Sagging
Patient No.	+/N	MM	+/N	+/N	+/N	+/N	+
1	N	5.2	N	+	+	+	N
2	N	3.8	N	N	N	N	N
3	N	3.8	+	N	+	+	+
4	N	6.3	+	+	+	+	+
5	+	11.7	+	N	+	+	+
6	+	8.0	+	+	N.P.	+	+
7	+	6.7	+	+	N.P.	+	N
8	+	6.0	+	N	N.P.	N	N
9	+	8.3	+	+	+	+	N
10	+	8.1	+	N	N	N	N
11	N	3.9	N	N	N	N	N
12	+	7.7	+	N	+	+	N
13	N	3.0	+	N	+	+	N
14	N	6.4	+	+	N.P.	+	N
15	+	7.1	+	+	N.P.	N	N
16	+	9.6	+	N	+	N	+
17	+	7.6	+	+	+	+	N
18	+	9.6	+	+	+	+	N
19	+	7.8	+	N	+	+	+
Frequency	63%		84%	47%	79%	68%	32%
95% CI	38%–84%		60%–97%	24%–71%	49%–95%	43%–87%	13%–57%
κ^c			0.775	0.579	0.869	1	0.652
ICC^c	0.974

a + indicates increased value (for quantitative measurement of the pituitary height); +, positive (for qualitative signs).
b Maximum normal pituitary height is 5.6 mm (men), 6.9 mm (women, 16–40 years of age), 5.8 mm (women, 41–62 years of age), and 6.0 mm (women, >62 years of age).¹⁰
c ICC and κ values were computed for the results of 3 readers.